← All trials
NCT06212336
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2024
- Primary completion
- Jun 30, 2027
- Completion date
- Jun 30, 2027
- First posted
- Jan 18, 2024
- Last posted
- Jan 18, 2024
- Enrollment
- 1755
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Irrua Specialist Teaching HospitalLead sponsor
- University of HamburgCollaborator
- Federal Medical Centre, OwoCollaborator
- Medecins Sans FrontieresCollaborator
- University of BordeauxCollaborator
- Centre de Recherche Médicale de LambarénéCollaborator
- Bernhard Nocht Institute for Tropical MedicineCollaborator
- Alex Ekwueme Federal University Teaching HospitalCollaborator
- Alliance for International Medical ActionCollaborator
- Government of Cote d'IvoireCollaborator
- Government of FranceCollaborator
- University of North Carolina at Chapel HillCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.